J. Maler

发表

Amyloid-β 42/40 cerebrospinal fluid concentration ratio in the diagnostics of Alzheimer's disease: validation of two novel assays.

P. Lewczuk, J. Kornhuber, P. Spitzer, 2014, Journal of Alzheimer's disease : JAD.

Neurochemical diagnosis of Alzheimer’s dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau

Juan Manuel Maler, Andreas Wolfram Henkel, Johannes Kornhuber, 2004, Neurobiology of Aging.

Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau.

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2004, Neurobiology of aging.

Absolute SPECT/CT quantification of cerebral uptake of 99mTc-HMPAO for patients with neurocognitive disorders

J. Kornhuber, T. Kuwert, J. Maler, 2015, Nuklearmedizin.

Preanalytical sample handling and sample stability testing for the neurochemical dementia diagnostics.

P. Lewczuk, J. Kornhuber, O. Ganslandt, 2011, Journal of Alzheimer's disease : JAD.

Serum neurofilament light chain in behavioral variant frontotemporal dementia

K. Fliessbach, Hans Förstl, H. Huppertz, 2018, Neurology.

Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease.

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2004, Biological psychiatry.

Electrophoretic separation of amyloid β peptides in plasma

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2004 .

Homocysteine induces cell death of rat astrocytes in vitro

J. Kornhuber, J. Wiltfang, S. Bleich, 2003, Neuroscience Letters.

Repetitive TMS Optimized by SPECT Control in Refractory Depression

J. Kornhuber, W. Sperling, T. Kraus, 2012 .

Amyloidogenic amyloid-β-peptide variants induce microbial agglutination and exert antimicrobial activity

Daniel F Gilbert, J. Kornhuber, P. Spitzer, 2016, Scientific Reports.

Elevated homocysteine levels in alcohol withdrawal.

E. Rüther, J. Kornhuber, J. Wiltfang, 2000, Alcohol and alcoholism.

Persecution-Induced Reduction in Earning Capacity of Holocaust Victims: Influence of Psychiatric and Somatic Aspects

W. Sperling, J. Maler, F. Seifert, 2011, Psychopathology.

Pharmacological inhibition of APP processing and knock-down of APP in primary human macrophages impairs the secretion of cytokines

J. Kornhuber, P. Spitzer, J. Maler, 2019 .

Facilitative effects of VNS on the motor threshold: implications for its antidepressive mode of action?

J. Kornhuber, W. Sperling, U. Reulbach, 2013, Journal of Neural Transmission.

Phagocytosis and LPS alter the maturation state of β-amyloid precursor protein and induce different Aβ peptide release signatures in human mononuclear phagocytes

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2010, Journal of Neuroinflammation.

Lithium Decreases Secretion of Aβ1–42 and C-Truncated Species Aβ1–37/38/39/40 in Chicken Telencephalic Cultures but Specifically Increases Intracellular Aβ1–38

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2004, Neurodegenerative Diseases.

Light‐induced exocytosis in cell development and differentiation

J. Kornhuber, J. Wiltfang, U. Reulbach, 2006, Journal of cellular biochemistry.

International quality control survey of neurochemical dementia diagnostics

P. Lewczuk, H. Hampel, J. Kornhuber, 2006, Neuroscience Letters.

The amyloid-beta (Abeta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Abeta peptide.

P. Lewczuk, E. Rüther, J. Kornhuber, 2003, Rapid communications in mass spectrometry : RCM.

Decreased circulating CD34+ stem cells in early Alzheimer's disease: evidence for a deficient hematopoietic brain support?

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2006, Molecular Psychiatry.

Electrophoretic separation of amyloid beta peptides in plasma.

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2004, Electrophoresis.

Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load.

F. Jessen, P. Lewczuk, H. Hampel, 2007, Journal of neurochemistry.

Urea‐based two‐dimensional electrophoresis of beta‐amyloid peptides in human plasma: Evidence for novel Aβ species

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2007, Proteomics.

Correlation Between Homocysteine Serum Levels and the Duration of Seizures in Patients Treated With Electroconvulsive Therapy

J. Kornhuber, W. Sperling, J. Maler, 2012, The journal of ECT.

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease

K. Blennow, P. Lewczuk, J. Kornhuber, 2015, Alzheimer's Research & Therapy.

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

K. Blennow, P. Lewczuk, J. Kornhuber, 2018, Alzheimer's Research & Therapy.

Kidney-transplant patients receiving living- or dead-donor organs have similar psychological outcomes (findings from the PI-KT study)

J. Kornhuber, K. Eckardt, M. Englbrecht, 2020, Mental illness.

Agomelatine reduces craving in benzodiazepine addicts: a follow-up examination of three patients.

J. Kornhuber, W. Sperling, J. Maler, 2012, Singapore medical journal.

Intrathecal IgG synthesis in patients with alterations in the neurochemical dementia diagnostics.

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2010, Journal of Alzheimer's disease : JAD.

Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer’s disease

Juan Manuel Maler, Johannes Kornhuber, Markus Otto, 2007, Journal of Molecular Neuroscience.

The Role of Cathepsin B in the Degradation of Aβ and in the Production of Aβ Peptides Starting With Ala2 in Cultured Astrocytes

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2021, Frontiers in Molecular Neuroscience.

Amyloid β peptide ratio 42/40 but not Aβ42 correlates with phospho‐Tau in patients with low‐ and high‐CSF Aβ40 load

F. Jessen, P. Lewczuk, H. Hampel, 2007 .

Spot quantification in two dimensional gel electrophoresis image analysis: comparison of different approaches and presentation of a novel compound fitting algorithm

Jan M. Brauner, Teja W. Groemer, Armin Stroebel, 2014, BMC Bioinformatics.

Memantine inhibits ethanol-induced NMDA receptor up-regulation in rat hippocampal neurons

P. Lewczuk, E. Rüther, J. Kornhuber, 2005, Brain Research.

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls

K. Blennow, P. Lewczuk, J. Kornhuber, 2015, Alzheimer's Research & Therapy.

Cerebrospinal Fluid of Patients With Alzheimer’s Disease Contains Increased Percentages of Synaptophysin-Bearing Microvesicles

J. Kornhuber, P. Spitzer, M. Herrmann, 2021, Frontiers in Aging Neuroscience.

Pharmacological Inhibition of Amyloidogenic APP Processing and Knock-Down of APP in Primary Human Macrophages Impairs the Secretion of Cytokines

J. Kornhuber, P. Spitzer, J. Maler, 2020, Frontiers in Immunology.

Analysis of Surface Levels of IL-1 Receptors and Macrophage Scavenger Receptor I in Peripheral Immune Cells of Patients With Alzheimer Disease

P. Lewczuk, J. Kornhuber, P. Spitzer, 2019, Journal of geriatric psychiatry and neurology.

Molecular Biology of Alzheimer’s Dementia and Its Clinical Relevance to Early Diagnosis and New Therapeutic Strategies

J. Kornhuber, J. Wiltfang, S. Bleich, 2001, Gerontology.

cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases

K. Blennow, H. Soininen, L. Buée, 2010, International journal of Alzheimer's disease.

Astrocytes and microglia but not neurons preferentially generate N-terminally truncated Aβ peptides

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2015, Neurobiology of Disease.

CD133-Positive Membrane Particles in Cerebrospinal Fluid of Patients with Inflammatory and Degenerative Neurological Diseases

S. Kloska, P. Spitzer, D. Corbeil, 2017, Front. Cell. Neurosci..

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study

F. Jessen, I. Heuser, P. Lewczuk, 2010, Molecular Psychiatry.

Imbalance of Circulating Th17 and Regulatory T Cells in Alzheimer’s Disease: A Case Control Study

J. Kornhuber, P. Spitzer, M. Herrmann, 2018, Front. Immunol..

Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization.

K. Blennow, J. Molinuevo, P. Lewczuk, 2016, Journal of Alzheimer's disease : JAD.

Nonsteroidal Anti-Inflammatory Drugs and Ectodomain Shedding of the Amyloid Precursor Protein

J. Wiltfang, S. Weggen, J. Maler, 2008, Neurodegenerative Diseases.

The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes

J. Kornhuber, M. Köhrmann, W. Sperling, 2010, Schizophrenia Research.

The amyloid-β (Aβ) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Aβ peptide

P. Lewczuk, E. Rüther, J. Kornhuber, 2003 .

Depression, Anxiety, Resilience and Coping Pre and Post Kidney Transplantation – Initial Findings from the Psychiatric Impairments in Kidney Transplantation (PI-KT)-Study

J. Kornhuber, S. Titze, K. Eckardt, 2015, PloS one.

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

K. Blennow, P. Lewczuk, J. Kornhuber, 2018, Alzheimer's Research & Therapy.

Plasma concentrations of the amyloid-β peptides in young volunteers: the influence of the APOE genotype.

P. Lewczuk, J. Kornhuber, M. Rauh, 2014, Journal of Alzheimer's disease : JAD.

Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: A multicenter study

F. Jessen, H. Vanderstichele, P. Lewczuk, 2008, Neurobiology of Aging.

Amyloid b peptide ratio 42 / 40 but not A b 42 correlates with phospho-Tau in patients with low-and high-CSF A b 40 load

F. Jessen, P. Lewczuk, H. Hampel, 2007 .

Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid beta peptides.

Juan Manuel Maler, Johannes Kornhuber, Georg Beck, 2006, Clinical chemistry.

Ventricular and lumbar cerebrospinal fluid concentrations of Alzheimer's disease biomarkers in patients with normal pressure hydrocephalus and posttraumatic hydrocephalus.

P. Lewczuk, J. Kornhuber, M. Buchfelder, 2014, Journal of Alzheimer's disease : JAD.

Usefulness of a Tailored eHealth Service for Informal Caregivers and Professionals in the Dementia Treatment and Care Setting: The eHealthMonitor Dementia Portal

Stefan Kirn, Juan Manuel Maler, Haridimos Kondylakis, 2016, JMIR research protocols.

Microwave-assisted Derivatization of Glucose and Galactose for Gas Chromatographic Determination in Human Plasma

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2006 .

N-truncation and pyroglutaminylation enhances the opsonizing capacity of Aβ-peptides and facilitates phagocytosis by macrophages and microglia

J. Kornhuber, P. Spitzer, M. Herrmann, 2014, Brain, Behavior, and Immunity.

Amyloid-β levels and cognitive trajectories in non-demented pTau181-positive subjects without amyloidopathy

P. Lewczuk, J. Kornhuber, P. Spitzer, 2022, Brain : a journal of neurology.

Adherence-dependent shifts in the patterns of β-amyloid peptides secreted by human mononuclear phagocytes

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2008, Brain, Behavior, and Immunity.

A Specific Reduction in Aβ1−42 vs. a Universal Loss of Aβ Peptides in CSF Differentiates Alzheimer's Disease From Meningitis and Multiple Sclerosis

P. Lewczuk, J. Kornhuber, P. Spitzer, 2018, Front. Aging Neurosci..

Measurement of ERK 1/2 in CSF from patients with neuropsychiatric disorders and evidence for the presence of the activated form.

F. Jessen, I. Heuser, P. Lewczuk, 2009, Journal of Alzheimer's disease : JAD.

Amyloid β peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2004, Biological Psychiatry.

Microvesicles from cerebrospinal fluid of patients with Alzheimer’s disease display reduced concentrations of tau and APP protein

P. Lewczuk, J. Kornhuber, P. Spitzer, 2019, Scientific Reports.

Distinct fractional Aβ release patterns in human mononuclear phagocytes

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2009, Journal of Neuroimmunology.

Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy

P. Lewczuk, S. Schwab, T. Engelhorn, 2023, Brain communications.

Low amounts of bisecting glycans characterize cerebrospinal fluid-borne IgG

G. Schett, P. Spitzer, R. Bilyy, 2018, Journal of Neuroimmunology.

The Effects of Stimulation Parameters on Clinical Outcomes in Patients With Vagus Nerve Stimulation Implants With Major Depression

J. Kornhuber, W. Sperling, J. Maler, 2013, The journal of ECT.

Psychological risk factors of kidney transplant patients.

J. Kornhuber, W. Gwinner, J. Maler, 2010, Kidney international.

Antidepressant drugs modulate growth factors in cultured cells

J. Kornhuber, J. Wiltfang, W. Sperling, 2008, BMC pharmacology.

Amyloid β peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2004, Biological Psychiatry.

Measurement of ERK 1/2 in CSF from patients with neuropsychiatric disorders and evidence for the presence of the activated form.

F. Jessen, I. Heuser, P. Lewczuk, 2009, Journal of Alzheimer's disease : JAD.

Digit Ratio (2D:4D) Is Not Associated with Alzheimer’s Disease in the Elderly

J. Maler, B. Lenz, C. Mühle, 2023, Brain sciences.